Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection and...

Full description

Bibliographic Details
Main Authors: Aleksandra Skwarek, Aleksandra Gąsecka, Miłosz J. Jaguszewski, Łukasz Szarpak, Tomasz Dzieciątkowski, Krzysztof J. Filipiak
Format: Article
Language:English
Published: Termedia Publishing House 2021-10-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.archivesofmedicalscience.com/Nanoparticles-a-breakthrough-in-COVID-19-prevention-diagnosis-and-treatment,142103,0,2.html
_version_ 1797435430202769408
author Aleksandra Skwarek
Aleksandra Gąsecka
Miłosz J. Jaguszewski
Łukasz Szarpak
Tomasz Dzieciątkowski
Krzysztof J. Filipiak
author_facet Aleksandra Skwarek
Aleksandra Gąsecka
Miłosz J. Jaguszewski
Łukasz Szarpak
Tomasz Dzieciątkowski
Krzysztof J. Filipiak
author_sort Aleksandra Skwarek
collection DOAJ
description Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection and targeted treatment. Vaccine-based prevention together with early detection has already proven its efficacy in controlling the pandemic. Early detection of infected patients could substantially accelerate the implementation of treatment, but also help to identify infection hotspots, whereas targeted treatment might destroy the virus and minimize damage to healthy tissue. Nanoparticles hold great promise with respect to these aspects. They may also be the solution to emerging clinical problems such as reinfection, pregnancy-related COVID-19 and coinfection. Here, we aim to discuss the potential applications of nanoparticles to combat the COVID-19 pandemic.
first_indexed 2024-03-09T10:48:00Z
format Article
id doaj.art-031a9c17acb74ba6a15ba981a4f6e4a7
institution Directory Open Access Journal
issn 1734-1922
1896-9151
language English
last_indexed 2024-03-09T10:48:00Z
publishDate 2021-10-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj.art-031a9c17acb74ba6a15ba981a4f6e4a72023-12-01T09:49:08ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512021-10-011951410142010.5114/aoms/142103142103Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatmentAleksandra Skwarek0Aleksandra Gąsecka1Miłosz J. Jaguszewski2Łukasz Szarpak3Tomasz Dzieciątkowski4Krzysztof J. Filipiak51st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland1st Department of Cardiology, Medical University of Gdansk, Gdansk, PolandMaria Skłodowska-Curie Medical Academy, Warsaw, PolandDepartment of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, PolandCoronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection and targeted treatment. Vaccine-based prevention together with early detection has already proven its efficacy in controlling the pandemic. Early detection of infected patients could substantially accelerate the implementation of treatment, but also help to identify infection hotspots, whereas targeted treatment might destroy the virus and minimize damage to healthy tissue. Nanoparticles hold great promise with respect to these aspects. They may also be the solution to emerging clinical problems such as reinfection, pregnancy-related COVID-19 and coinfection. Here, we aim to discuss the potential applications of nanoparticles to combat the COVID-19 pandemic.https://www.archivesofmedicalscience.com/Nanoparticles-a-breakthrough-in-COVID-19-prevention-diagnosis-and-treatment,142103,0,2.htmlcoronavirus disease 2019covid-19sars-cov-2nanoparticles
spellingShingle Aleksandra Skwarek
Aleksandra Gąsecka
Miłosz J. Jaguszewski
Łukasz Szarpak
Tomasz Dzieciątkowski
Krzysztof J. Filipiak
Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
Archives of Medical Science
coronavirus disease 2019
covid-19
sars-cov-2
nanoparticles
title Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title_full Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title_fullStr Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title_full_unstemmed Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title_short Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title_sort nanoparticles a breakthrough in covid 19 prevention diagnosis and treatment
topic coronavirus disease 2019
covid-19
sars-cov-2
nanoparticles
url https://www.archivesofmedicalscience.com/Nanoparticles-a-breakthrough-in-COVID-19-prevention-diagnosis-and-treatment,142103,0,2.html
work_keys_str_mv AT aleksandraskwarek nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment
AT aleksandragasecka nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment
AT miłoszjjaguszewski nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment
AT łukaszszarpak nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment
AT tomaszdzieciatkowski nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment
AT krzysztofjfilipiak nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment